Astronics

ATRO · NASDAQ

$59.85−$2.48 (−3.98%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $62.33

ATRO analyst rating

BuyConsensus of 2 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy2
Hold0
Underperform0
Sell0

12-month price target · 7 analysts

Average $93.20 (+55.7% upside)

Low: $55.43
Now: $59.85
High: $112.35

Upgrades and downgrades

The latest rating actions, newest first

ATRO analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
TD Cowen	Oct 9, 2026	Maintains	Buy	$100.00 → $90.00	63%
TD Cowen	May 28, 2026	Maintains	Buy	$85.00 → $100.00	63%
Truist Securities	Feb 25, 2026	Maintains	Buy	$75.00 → $107.00	71%
TD Cowen	Nov 26, 2025	Initiates	Buy	$65.00	63%

The case for and against

Updated Nov 24, 2024

Bull case

Astronics Corp has demonstrated robust growth across its segments, with Test Systems sales rising 34% year-over-year to $26.5 million, primarily fueled by increased demand for radio testing. The Aerospace segment also exhibited strong performance, achieving a 22% year-over-year increase to $169 million, driven by notable gains in both military and commercial transportation markets. Additionally, the company's improved operational margins, with consolidated op margins at 3.8% and Aerospace segment margins reaching 10.9%, reflect a positive trend in profitability, positioning Astronics favorably for continued revenue and margin growth moving forward.

Bear case

Astronics Corp's outlook appears negative due to a combination of factors impacting profitability and cash generation, primarily stemming from ongoing supply chain pressures and challenges associated with the recent refinancing of its debt. The company's expected first-quarter sales of $170-$175 million reflect a 4.4% miss against consensus estimates, raising concerns about its ability to meet financial projections. While the aerospace segment shows some strength with margins hitting multi-year highs, the underlying struggles in the Test Systems segment and potential inventory issues in the channel pose additional risks to the company’s overall financial health.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.